Back to search
Creutzfeldt-Jakob Disease (CJD) | Prion Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Creutzfeldt-Jakob Disease (CJD) | Prion Disease trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Creutzfeldt-Jakob Disease (CJD) | Prion Disease trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The purpose of this trial is to evaluate safety, tolerability, pharmacokinetics and pharmacodynamic impact of PrP-siRNA in symptomatic prion disease patients.
We are doing this research to identify biomarkers in individuals who are at-risk for familial prion disease. We hope to use these biomarkers to predict timing o…
FLOWER is a completely virtual, nationwide, real-world observational study to collect, annotate, standardize, and report clinical data for rare diseases. Patien…
Creutzfeldt-Jakob Disease (CJD) is the most common prion disease in humans causing a rapidly progressive neurological decline and dementia and is invariably fat…
The goal of this clinical trial is to improve communication among clinicians, patients with memory problems, and their family members. We are testing a way to h…
Creutzfeldt-Jakob disease (CJD) is a rare and rapidly progressive neurological disorder. This study aims to describe and summarize the key features of CJD by lo…